Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the first quarter of 2023...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.74%....
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.31%. U.S. stock...
Morning Markets March S&P 500 futures (ESH2 3) this morning are up +0.74%, and March Nasdaq 100 E-Mini futures (NQH2 3) are up +0.90%. U.S. stock index futures this morning are trading higher on increased...
Thanks to sales of its Zephyr valve, the company's revenue is growing.
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, has partnered with American Lung Association to provide education to patients...
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW)...
Investors are reacting negatively to the company's planned securities offering.
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at the...
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in fireside chats at two upcoming...